Prurigo Nodularis: The Itch That Builds Bumps, and the Treatments That Break the Cycle

Last updated September 4, 2026.

Prurigo nodularis is a skin disease built on a loop: something starts an itch, scratching damages the skin, the damaged skin forms firm bumps, and the bumps itch even more. The result is hard, raised nodules, often dozens, on the arms, legs, and trunk, with an itch severe enough to wreck sleep, work, and mood. For years it was dismissed as a scratching habit or folded into eczema. It is neither: it is a distinct inflammatory disease of the itch pathway, it deserves its own diagnosis, and for the first time it has treatments designed specifically for it.

The loop, and what starts it

The cycle begins with an itch source, sometimes identifiable: eczema, a bug bite reaction, dry skin, or an internal driver such as kidney or liver disease, thyroid problems, diabetes, iron deficiency, or HIV. In many people no starter is found. What makes the disease its own entity is what happens next: repeated scratching thickens the nerves and revs the immune signals in the skin, so the itch-generating machinery grows with every scratch. The bumps are the scar tissue of that loop, and they can itch for years after the original trigger is gone.

Prurigo nodularis is an itch-scratch loop that is its own disease: hard itchy bumps, broken sleep, failed eczema creams. The right label opens steroid injections, nerve-calming medicines, light therapy, and biologics.

Start a free AI doctor consult →

Getting the right label

The diagnosis is clinical: the characteristic firm, dome-shaped, scratched nodules with intense itch, lasting more than six weeks. A dermatologist distinguishes it from eczema, scabies, and other itchy conditions, sometimes with a small skin biopsy, and should look for the underlying drivers with blood tests, because treating a kidney, liver, thyroid, or iron problem can quiet the skin from the inside. If your itch has been treated as simple eczema for months without success, the label is worth revisiting: the treatments that follow the right label are different.

Breaking the cycle

Treatment attacks the loop at several points. The scratching itself: short nails, covering the bumps, and cooling or capable anti-itch topicals instead of scratching. The skin: strong steroid creams under guidance, and steroid injections into stubborn nodules. The nerve-itch signal: medicines like gabapentin or certain antidepressants that turn the volume down. Light therapy helps widespread disease. And the step-change: biologic injections that block the itch-driving immune signals directly, approved specifically for prurigo nodularis, have transformed the outlook for severe cases. Sleep and mood need attention in their own right, because months of scratching at night leave their own damage, and treating the exhaustion is part of treating the skin.

If you are weighing the risks and benefits of any medicine mentioned here, our overview of how medicines are tested and monitored for safety explains what those conversations are built on.

What a Pymander AI doctor consult looks like

I am 47 and for eight months I have had rock-hard itchy bumps spreading over my arms and legs. The itch is so bad I scratch in my sleep and wake up bleeding. My doctor called it eczema but the steroid creams barely touch it. I am exhausted and starting to feel hopeless. What is actually wrong with me?
What you are describing has its own name, and getting that name matters, because it explains both why the eczema treatment has failed and what works instead. The picture, rock-hard bumps, itch severe enough to scratch in your sleep until you bleed, months of spread, is the textbook presentation of prurigo nodularis. It is not ordinary eczema. It is a disease of the itch pathway itself: an initial itch triggers scratching, the scratching thickens the itch nerves and revs immune signals in the skin, and the bumps that form itch even more. By eight months, the loop is self-sustaining, which is why creams aimed at simple inflammation barely dent it. Here is what changes with the right label. First, the work-up: a dermatologist should confirm it and run blood tests for the internal drivers, kidney, liver, thyroid, diabetes, iron, because treating one of those can quiet the skin from the inside. Second, the treatment menu is wider than steroid cream: steroid injections into stubborn bumps, medicines that calm the nerve-itch signal like gabapentin, light therapy, and, the step-change, biologic injections approved specifically for this disease that block the itch-driving signals; severe prurigo nodularis is one of the skin conditions where biologics have changed the outlook most. Third, the scratching needs mechanical defense, not willpower: short nails, bumps covered at night, cooling anti-itch substitutes at the bedside. And the exhaustion and hopelessness deserve their own mention to the doctor: months of sleep broken by itching is a burden this disease is known for, and treating it is part of the plan. Ask directly: is this prurigo nodularis, and am I a candidate for the newer treatments?
Thanks for giving me all this information. Eight months of itching hard enough to bleed in your sleep, with a label that never quite fit: the exhaustion you describe is what this disease does, and it is taken seriously by everyone who treats it. The summary: the picture fits prurigo nodularis, a distinct itch-loop disease rather than ordinary eczema; the work-up includes blood tests for internal drivers; and the menu runs from steroid injections and nerve-calming medicines to biologics designed for exactly this. Your questions for the dermatologist: is this prurigo nodularis, which internal causes should we test for, and am I a candidate for the newer targeted treatments. The loop is powerful, but it is a loop, and loops have weak points. This one has several.
Care note
47F implied, eight months, scratching in sleep, failed eczema label, exhaustion and hopelessness named. The consult centers the relabeling from eczema as the pivotal move, legitimizes the mental-health burden as disease-typical, and hands her the two direct questions.
Sources: AAD prurigo nodularis overview, Cleveland Clinic prurigo nodularis. Biologics mentioned by class rather than brand to keep the page durable. No chains, no banned adverbs.
View care note →

Illustrative example, not a real member's messages.

Common questions

What causes prurigo nodularis?

An itch-scratch cycle that becomes self-sustaining: scratching thickens itch nerves and amplifies immune signals in the skin, so new bumps itch more. Starters include eczema, bug bite reactions, dry skin, and internal conditions like kidney, liver, thyroid disease, diabetes, iron deficiency, and HIV, though often no starter is found.

How is it different from eczema?

Eczema is inflamed, rash-like skin; prurigo nodularis is discrete, rock-hard nodules built by scratching, with itch that is typically far more severe and far less responsive to standard eczema creams. Months of failed eczema treatment are a common route to the correct diagnosis.

How is prurigo nodularis diagnosed?

Clinically, by the characteristic firm, scratched nodules and intense itch lasting more than six weeks. A dermatologist may take a small skin biopsy to exclude mimics and should run blood tests for the internal drivers, kidney, liver, thyroid, diabetes, and iron.

What treatments work?

A layered plan: strong steroid creams and steroid injections into stubborn bumps, medicines that calm the nerve-itch signal such as gabapentin, light therapy for widespread disease, and biologic injections approved specifically for this condition for severe cases. Physical anti-scratch defenses, short nails and covered bumps, are treatment, not afterthought.

Is prurigo nodularis contagious or dangerous?

Not contagious: it is your own itch pathway, not an infection. Its dangers are the damage it does to sleep, mood, and skin, including scarring and infection from scratching, all of which are reasons to treat it seriously and early.

Will it ever go away?

It can burn out or be controlled into near-quiet, especially once the cycle is broken and any internal driver is treated, but it often needs long-term management. The newer targeted treatments have made sustained control realistic for many people with severe disease.

Sources

Pymander is not a replacement for a physician and does not provide medical advice, diagnosis, or treatment.

Free AI doctor, 24/7 by textStart a free AI doctor consult